Name: Pregnancy and the Pharmaceutical Industry: The Movement Towards Evidence-Based Pharmacotherapy for Pregnant Women (en Inglés)
Price: 406.87 PEN
Availability: InStock
Author: Kristine E. Shields
ISBN: 9780128185506

portada Pregnancy and the Pharmaceutical Industry: The Movement Towards Evidence-Based Pharmacotherapy for Pregnant Women (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Kristine E. Shields

Año

2019

Idioma

Inglés

N° páginas

244

Encuadernación

Tapa Blanda

ISBN13

9780128185506

N° edición

Categorías

Farmacología

Pregnancy and the Pharmaceutical Industry: The Movement Towards Evidence-Based Pharmacotherapy for Pregnant Women (en Inglés)

Kristine E. Shields (Autor) · Academic Press · Tapa Blanda

Libro Físico

S/ 406,87

S/ 813,75

Ahorras: S/ 406,87

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 17 de Julio y el Jueves 01 de Agosto.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Pregnancy and the Pharmaceutical Industry: The Movement Towards Evidence-Based Pharmacotherapy for Pregnant Women (en Inglés)"

Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy as it is impossible to extrapolate that information from drug studies on men and non-pregnant women. As a majority of pregnant women confront a medical condition during their pregnancy, from simple pain, to ongoing or new medical issues, this book quantifies the current absence of pregnant women in drug studies and identifies ethical issues, barriers, litigation fears and opportunities. Those in the pharmaceutical industry, IRB members who approve or deny drug study plans, doctors, nurses and midwives working in obstetrics or involved in conducting studies at their institutions will find this book an essential resource.Explores the medical, ethical, scientific and legal rationales behind the inclusion of pregnant women in drug studiesDescribes how pharma and biotech companies can safely implement the new FDA guidance and begin to include pregnant women in drug testingShares views from pharmaceutical industry insiders about company risks, reluctance to implement guidance, and the ultimate need to include pregnant women in studies